R2 resection in pancreatic cancer—does it make sense?
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2008/02/29
-
Journal
-
Indian UGC (journal)
-
Refrences21
-
Citations18
-
Jörg Köninger
-
Moritz N. Wente
-
Beat P. Müller-Stich
-
Francesco F. di Mola
-
Carsten N. Gutt
-
Ulf Hinz
-
Michael W. Müller
-
Helmut Friess
-
Markus W. Büchler
Cite
Köninger, Jörg, et al. “R2 Resection in Pancreatic cancer—does It Make Sense?”. Langenbeck’s Archives of Surgery, vol. 393, no. 6, 2008, pp. 929-34, https://doi.org/10.1007/s00423-008-0308-4.
Köninger, J., Wente, M. N., Müller-Stich, B. P., di Mola, F. F., Gutt, C. N., Hinz, U., Müller, M. W., Friess, H., & Büchler, M. W. (2008). R2 resection in pancreatic cancer—does it make sense?. Langenbeck’s Archives of Surgery, 393(6), 929-934. https://doi.org/10.1007/s00423-008-0308-4
Köninger, Jörg, Moritz N. Wente, Beat P. Müller-Stich, Francesco F. di Mola, Carsten N. Gutt, Ulf Hinz, Michael W. Müller, Helmut Friess, and Markus W. Büchler. “R2 Resection in Pancreatic cancer—does It Make Sense?”. Langenbeck’s Archives of Surgery 393, no. 6 (2008): 929-34. https://doi.org/10.1007/s00423-008-0308-4.
Köninger J, Wente MN, Müller-Stich BP, di Mola FF, Gutt CN, Hinz U, et al. R2 resection in pancreatic cancer—does it make sense?. Langenbeck’s Archives of Surgery. 2008;393(6):929-34.
Journal Categories
Medicine
Medicine (General)
Medicine
Surgery
You May Also Like
- Peritoneal Adhesions: Etiology, Pathophysiology, and Clinical Significance
- Liver Anatomy: Portal (and Suprahepatic) or Biliary Segmentation
- Recalling Superior Mesenteric Artery Syndrome
- 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
- Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas | The American Journal of Surgery |
| 64 | 2008 |
| Transforming growth factor-β: What every pancreatic surgeon should know | Surgery |
| 8 | 2007 |
| Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial | British Journal of Cancer |
| 60 | 2007 |
| Microscopically incomplete resection offers acceptable palliation in pancreatic cancer | Surgery |
| 39 | 2006 |
Redefining the R1 resection in pancreatic cancer | British Journal of Surgery |
| 412 | 2006 |
Refrences Analysis
The category
Medicine: Medicine (General) 21
is the most frequently represented among the references in this article. It primarily includes studies from Surgery and Annals of Surgery. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Curing pancreatic cancer | Seminars in Cancer Biology |
| 19 | 2021 |
Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer? | Anti-Cancer Drugs |
| 2021 | |
Surgical and survival outcomes after robotic and open pancreaticoduodenectomy with positive margins | Journal of the Chinese Medical Association |
| 2021 | |
| All Positives May Not Be the Same in Pancreatic Cancer | American Journal of Clinical Oncology |
| 2020 | |
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option | Canadian Journal of Gastroenterology and Hepatology |
| 1 | 2020 |
Citations Analysis
The category
Medicine: Medicine (General) 16
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly and was published in 2009. The most recent citation comes from a 2021 study titled Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer?. This article reached its peak citation in 2021, with 3 citations. It has been cited in 16 different journals, 6% of which are open access. Among related journals, the Langenbeck's Archives of Surgery cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.